Page 3 - Oncology
Discover Spirochrome’s Latest Fluorescent Probes: Transform Your Cell Imaging
As the complexity of cellular research grows, scientists need tools that are precise, versatile, and easy to use. To meet these demands, Spirochrome has
Redefining Plasma Membrane Imaging: Discover the Power of PKmem™ Probes
Introducing PKmem™ Probes: Crossing Cellular Boundaries with Precision
In cellular research, precisely visualising the plasma membrane can unlock critical insights.
Revolutionising Research: The First Small-Molecule Probes to Specifically Label Peroxisomes
Streamlining Peroxisome Imaging: A New Era with Peroxi_SPY Probes
In the world of scientific research, the need for efficient and reliable tools is
Unlocking the Next Frontier in Immuno-Oncology: Powering T and NK Cell Therapies with Nanotein’s Innovative Platforms
Powering T and NK Cell Therapies with Nanotein’s Innovative Platforms
In the ever-evolving field of immuno-oncology, the race to develop the most effective cell-based therapies has never been
Revolutionising mRNA Production: When Simplicity Meets Efficiency
mRNA-Based Therapeutics: Pioneering the Future of Medicine
Over the past few years, mRNA-based therapeutics have emerged as a promising approach to treat various diseases, including
Optimising mRNA for Therapeutics: The Synergy of CleanCap Technology and Minimal UTRs
mRNA and UTRs: Unlocking New Frontiers in Therapeutic Innovation
Over the past five years, there has been an explosive surge in scientific interest surrounding messenger RNA (mRNA),
Virax Biolabs Announces Agreement with Tebubio to expand distribution of ImmuneSelect Across the European Union, Norway and Switzerland
Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune responses and diagnosis of viral diseases, today announced
Enhance Your Therapeutic mRNA Research Projects with Modified NTPs
How Modified NTPs are Revolutionising mRNA Vaccine Technology
In recent years, the spotlight on mRNA (messenger RNA) technology has intensified, largely due to its pivotal role
Screening of Optimal Conditions to Obtain a Difficult to Produce Protein in HEK 293 Cells
Obtaining high yields of pure and active difficult-to-produce recombinant proteins can be a real challenge and may require significant investment. The rapid screening of multiple production
Development of Cost Effective and Robust 3D Colorectal Cancer Models for Physiological Drug Response Analysis
Our customer needed to obtain in vivo like responses to drug treatment, through monitoring parameters such as gene expression, biomarker analysis,
Multiplex Antibody Array for Protein Profiling and Biostatistical Analysis to Assess the Effect of Oxaliplatin on Mouse Fibrosarcoma Cell Line
Oxaliplatin (OXA) is a chemotherapeutic drug which causes DNA cross-linking damage, preventing DNA replication and transcription and leading to cell death. Oxaliplatin is known as immunogenic cell death
Standardized 3D Spheroid Systems Facilitate Drug Screening and Biomarker Identification with High Relevance for Cancer Drug Discovery
Our customer needed to investigate whether modulating key culture parameters could improve the predictivity of their colorectal cancer cell-based methodology used to select